WuXi Biologics (Cayman) Inc. (HKG:2269)
26.00
+1.70 (7.00%)
Feb 21, 2025, 4:08 PM HKT
WuXi Biologics Employees
WuXi Biologics had 12,740 employees as of December 31, 2023. The number of employees increased by 367 or 2.97% compared to the previous year.
Employees
12,740
Change (1Y)
367
Growth (1Y)
2.97%
Revenue / Employee
1.48M HKD
Profits / Employee
227.44K HKD
Market Cap
106.51B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BeiGene | 10,600 |
JD Health International | 3,118 |
Hansoh Pharmaceutical Group Company | 9,123 |
Alibaba Health Information Technology | 1,435 |
Innovent Biologics | 4,872 |
Sinopharm Group | 115,959 |
Sino Biopharmaceutical | 25,806 |
Akeso | 2,778 |
WuXi Biologics News
- 4 days ago - WuXi Biologics Awarded Platinum Medal by EcoVadis Sustainability Rating for Second Consecutive Year - PRNewsWire
- 12 days ago - WuXi Biologics Recognized as ESG Top-Rated Company by Morningstar Sustainalytics - GuruFocus
- 12 days ago - WuXi Biologics Recognized as Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics for Fifth Consecutive Year - PRNewsWire
- 4 weeks ago - WuXi Biologics: Spotlight On Property Disposal And Operating Metrics (Rating Upgrade) - Seeking Alpha
- 6 weeks ago - WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million - The Wall Street Journal
- 6 weeks ago - WuXi Biologics to Sell Irish Vaccine Facility to Merck for $500 Million - WSJ
- 6 weeks ago - WuXi Bio to Sell Vaccine Facility to Merck for $500 Million - BNN Bloomberg
- 6 weeks ago - WuXi Biologics Announces Strategic Agreement with Candid Therapeutics - GuruFocus